Quick Takeaways
- Stephen Berenson has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,517,789.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Stephen Berenson
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Stephen Berenson is at least $2,517,789 dollars as of 02 Jul 2025. Stephen Berenson is the Director of Moderna, Inc. and owns shares of Moderna, Inc. (MRNA) stock worth about $2.52M.
- Signature
- /s/ Thomas J. DesRosier, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Stephen Berenson and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Moderna, Inc. ($2,517,789).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Stephen Berenson
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | Director | $2,517,789 | 03 May 2024 | ||
| MCRB | Seres Therapeutics, Inc. | Director | 01 Jul 2025 |
Insider Transactions Reported by Stephen Berenson:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.